NRX Pharmaceuticals Cash Flow Statement (2017-2026) | NRXP

Cash Flow Statement Dec2017 Mar2018 Jun2018 Sep2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
-0.12M-37.05M-30.41M-16.71M-9.75M-9.32M-12.31M-3.97M-8.09M-6.19M-4.41M-6.34M-7.04M-3.02M-2.43M-3.84M-3.73M-4.21M-4.62M-4.97M
Depreciation and Depletion (Quarter)
0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M-0.99M0.02M-0.02M2.00M-3.99M0.02M
Share-based Compensation (Quarter)
0.94M1.56M1.57M1.33M0.99M0.54M3.61M0.69M0.54M0.35M-1.59M0.24M0.10M0.10M0.04M0.07M0.07M-0.42M0.60M
Gains from Investment Securities (Quarter)
1.47M-0.26M-0.87M-0.16M-0.12M0.04M-0.02M-2.90M0.01M-0.03M0.01M0.01M-0.02M-0.17M1.83M-2.90M8.50M5.00M-3.48M-3.54M
Asset Writedowns and Impairment (Quarter)
0.03M
Cash from Operations (Quarter)
-11.39M-12.01M-11.28M-10.38M-14.79M-6.27M-8.32M-6.09M-7.81M-4.56M-3.19M-3.67M-2.56M-2.31M-2.10M-3.48M-4.03M-2.89M-3.70M-4.30M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
Amortization of Deferred Charges (Quarter)
0.01M0.06M0.10M
Depreciation & Amortization (CF) (Quarter)
0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M-0.02M0.03M0.04M0.06M
Change in Working Capital
Change in Receivables (Quarter)
-0.04M0.05M
Change in Account Payables (Quarter)
1.33M-0.71M-1.87M0.62M-1.23M-0.91M-0.09M1.70M-1.57M1.52M1.00M2.09M2.12M0.74M-10.17M0.18M-0.68M0.60M0.01M0.13M
Change in Accured Expenses (Quarter)
0.05M0.51M-0.31M1.64M-0.48M1.83M-0.05M0.30M0.57M-1.34M-0.07M-0.05M0.88M-0.94M10.11M-0.34M0.14M-0.21M0.91M-0.07M
Change in Taxes (Quarter)
Other Working Capital Changes (Quarter)
4.80M1.20M-1.24M-1.73M4.48M-1.31M-0.81M-0.49M-0.43M-0.63M-1.49M-0.25M0.90M-0.55M-0.60M-0.16M-0.03M-0.23M-0.45M-0.42M
Investing Activities
Capital Expenditures (Quarter)
0.00M0.00M0.00M0.01M-0.00M0.00M-0.00M0.00M-0.00M
Acquisitions (Quarter)
-0.18M
Cash from Investing Activities (Quarter)
-0.00M-0.00M-0.00M-0.00M-0.01M0.00M-0.00M0.00M-0.00M0.00M-0.25M-0.21M
Financing Activities
Other financing activities (Quarter)
3.55M9.20M-5.65M1.03M1.03M1.91M3.09M
Cash from Financing Activities (Quarter)
11.51M37.52M0.00M22.98M-0.86M-0.03M10.12M2.54M6.27M-1.50M-1.12M0.40M3.14M2.05M1.90M7.58M1.39M9.73M4.58M3.42M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter)
1.44M31.13M27.38M1.01M3.74M1.64M3.42M
Additional items
Change in Cash (Quarter)
0.12M25.50M-11.28M12.60M-15.65M-6.30M1.80M-3.55M-1.54M-6.07M-4.31M-3.28M0.58M-0.25M-0.20M4.11M-2.64M4.27M0.61M-1.08M
Free Cash Flow (Quarter)
-11.39M-12.02M-11.28M-10.38M-14.79M-6.27M-8.32M-6.09M-7.81M-4.57M-3.19M-3.67M-2.56M-2.31M-2.10M-3.48M-4.03M-2.89M-3.70M-4.30M
Net Cash Flow (Quarter)
0.12M25.50M-11.28M12.60M-15.65M-6.30M1.80M-3.55M-1.54M-6.07M-4.31M-3.28M0.58M-0.25M-0.20M4.11M-2.64M6.83M0.62M-1.09M